A Phase 3, Randomized, Double-Blind, Placebo-Controlled,

Project: Research project

Project Details

Description

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Confirming the Efficacy and Safety of Genz-112638 in Patients with Gaucher Disease Type 1 (ENGAGE)
StatusFinished
Effective start/end date7/1/1012/31/14

Funding

  • GENZYME CORPORATION

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.